Diagnostic and Prognostic Performance of Blood Plasma Glycan Features in the Women Epidemiology Lung Cancer (WELCA) Study

Yueming Hu, Shadi Ferdosi, Erandi P. Kapuruge, Jesús Aguilar Diaz De Leon, Isabelle Stücker, Loredana Radoï, Pascal Guénel, Chad R. Borges

Research output: Contribution to journalArticle

Abstract

Lung cancer is the leading cause of cancer death in women living in the United States, which accounts for approximately the same percentage of cancer deaths in women as breast, ovary and uterine cancers combined. Targeted blood plasma glycomics represents a promising source of non-invasive diagnostic and prognostic biomarkers for lung cancer. Here, 208 samples from lung cancer patients and 207 age-matched controls enrolled in the Women Epidemiology Lung Cancer (WELCA) study were analyzed by a bottom-up glycan "node" analysis approach. Glycan features, quantified as single analytical signals, including 2-linked mannose, α2-6 sialylation, β1-4 branching, β1-6 branching, 4-linked GlcNAc, and antennary fucosylation, exhibited abilities to distinguish cases from controls (ROC AUCs: 0.68-0.92) and predict survival in patients (hazard ratios: 1.99-2.75) at all stages. Notable alterations of glycan features were observed in stages I-II. Diagnostic and prognostic glycan features were mostly independent of smoking status, age, gender and histological subtypes of lung cancer.

Original languageEnglish (US)
JournalJournal of Proteome Research
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Epidemiology
Polysaccharides
Lung Neoplasms
Blood
Plasmas
Glycomics
Biomarkers
Mannose
Uterine Neoplasms
Aptitude
Hazards
Ovarian Neoplasms
Area Under Curve
Cause of Death
Neoplasms
Smoking
Breast Neoplasms
Survival

Keywords

  • branching
  • diagnostic
  • fucosylation
  • glycans
  • lung cancer
  • plasma
  • prognostic
  • sialylation
  • survival
  • women

ASJC Scopus subject areas

  • Biochemistry
  • Chemistry(all)

Cite this

Diagnostic and Prognostic Performance of Blood Plasma Glycan Features in the Women Epidemiology Lung Cancer (WELCA) Study. / Hu, Yueming; Ferdosi, Shadi; Kapuruge, Erandi P.; Diaz De Leon, Jesús Aguilar; Stücker, Isabelle; Radoï, Loredana; Guénel, Pascal; Borges, Chad R.

In: Journal of Proteome Research, 01.01.2019.

Research output: Contribution to journalArticle

Hu, Yueming ; Ferdosi, Shadi ; Kapuruge, Erandi P. ; Diaz De Leon, Jesús Aguilar ; Stücker, Isabelle ; Radoï, Loredana ; Guénel, Pascal ; Borges, Chad R. / Diagnostic and Prognostic Performance of Blood Plasma Glycan Features in the Women Epidemiology Lung Cancer (WELCA) Study. In: Journal of Proteome Research. 2019.
@article{d037acc7cc514fac8372b334086cf899,
title = "Diagnostic and Prognostic Performance of Blood Plasma Glycan Features in the Women Epidemiology Lung Cancer (WELCA) Study",
abstract = "Lung cancer is the leading cause of cancer death in women living in the United States, which accounts for approximately the same percentage of cancer deaths in women as breast, ovary and uterine cancers combined. Targeted blood plasma glycomics represents a promising source of non-invasive diagnostic and prognostic biomarkers for lung cancer. Here, 208 samples from lung cancer patients and 207 age-matched controls enrolled in the Women Epidemiology Lung Cancer (WELCA) study were analyzed by a bottom-up glycan {"}node{"} analysis approach. Glycan features, quantified as single analytical signals, including 2-linked mannose, α2-6 sialylation, β1-4 branching, β1-6 branching, 4-linked GlcNAc, and antennary fucosylation, exhibited abilities to distinguish cases from controls (ROC AUCs: 0.68-0.92) and predict survival in patients (hazard ratios: 1.99-2.75) at all stages. Notable alterations of glycan features were observed in stages I-II. Diagnostic and prognostic glycan features were mostly independent of smoking status, age, gender and histological subtypes of lung cancer.",
keywords = "branching, diagnostic, fucosylation, glycans, lung cancer, plasma, prognostic, sialylation, survival, women",
author = "Yueming Hu and Shadi Ferdosi and Kapuruge, {Erandi P.} and {Diaz De Leon}, {Jes{\'u}s Aguilar} and Isabelle St{\"u}cker and Loredana Rado{\"i} and Pascal Gu{\'e}nel and Borges, {Chad R.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1021/acs.jproteome.9b00457",
language = "English (US)",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",

}

TY - JOUR

T1 - Diagnostic and Prognostic Performance of Blood Plasma Glycan Features in the Women Epidemiology Lung Cancer (WELCA) Study

AU - Hu, Yueming

AU - Ferdosi, Shadi

AU - Kapuruge, Erandi P.

AU - Diaz De Leon, Jesús Aguilar

AU - Stücker, Isabelle

AU - Radoï, Loredana

AU - Guénel, Pascal

AU - Borges, Chad R.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Lung cancer is the leading cause of cancer death in women living in the United States, which accounts for approximately the same percentage of cancer deaths in women as breast, ovary and uterine cancers combined. Targeted blood plasma glycomics represents a promising source of non-invasive diagnostic and prognostic biomarkers for lung cancer. Here, 208 samples from lung cancer patients and 207 age-matched controls enrolled in the Women Epidemiology Lung Cancer (WELCA) study were analyzed by a bottom-up glycan "node" analysis approach. Glycan features, quantified as single analytical signals, including 2-linked mannose, α2-6 sialylation, β1-4 branching, β1-6 branching, 4-linked GlcNAc, and antennary fucosylation, exhibited abilities to distinguish cases from controls (ROC AUCs: 0.68-0.92) and predict survival in patients (hazard ratios: 1.99-2.75) at all stages. Notable alterations of glycan features were observed in stages I-II. Diagnostic and prognostic glycan features were mostly independent of smoking status, age, gender and histological subtypes of lung cancer.

AB - Lung cancer is the leading cause of cancer death in women living in the United States, which accounts for approximately the same percentage of cancer deaths in women as breast, ovary and uterine cancers combined. Targeted blood plasma glycomics represents a promising source of non-invasive diagnostic and prognostic biomarkers for lung cancer. Here, 208 samples from lung cancer patients and 207 age-matched controls enrolled in the Women Epidemiology Lung Cancer (WELCA) study were analyzed by a bottom-up glycan "node" analysis approach. Glycan features, quantified as single analytical signals, including 2-linked mannose, α2-6 sialylation, β1-4 branching, β1-6 branching, 4-linked GlcNAc, and antennary fucosylation, exhibited abilities to distinguish cases from controls (ROC AUCs: 0.68-0.92) and predict survival in patients (hazard ratios: 1.99-2.75) at all stages. Notable alterations of glycan features were observed in stages I-II. Diagnostic and prognostic glycan features were mostly independent of smoking status, age, gender and histological subtypes of lung cancer.

KW - branching

KW - diagnostic

KW - fucosylation

KW - glycans

KW - lung cancer

KW - plasma

KW - prognostic

KW - sialylation

KW - survival

KW - women

UR - http://www.scopus.com/inward/record.url?scp=85073463825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073463825&partnerID=8YFLogxK

U2 - 10.1021/acs.jproteome.9b00457

DO - 10.1021/acs.jproteome.9b00457

M3 - Article

C2 - 31566983

AN - SCOPUS:85073463825

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

ER -